Canada House Wellness Group Inc. (CNSX:CHV) (OTCMKTS:SARSF) (FRA:509A) is a vertically integrated company which has a unique approach in differentiating itself from other small licenced producers. The Health Canada licensed producer, who recently received their license to sell pot seeds (as per the acmpr website), is currently focused on the acquisition of new patients and helping all Canadians have access to medical cannabis. The Kira Award finalist, for their Knalysis technology platform, has currently 11 cannabis clinics in Canada. Utilizing these clinics and the Knalysis technologies app, they have integrated 4 years worth of data from thousands of patients in the Knalysis platform to help physicians know what strains, doses, pills, or oils to treat the Canadian population with medical marijuana.
Canada House Wellness Group Inc’s subsidiaries are the following:
Marijuana For Trauma Inc.
Treating complex health issues through ongoing
education, support, and data-driven cannabinoid
therapy treatment plans. MFTgroup.ca
Knalysis Technologies Inc.
Leveraging data generated by Canada House’s operations
to improve patient outcomes, optimize productivity and
drive profits. Knalysis.com
Abba Medix Corp.
Producing efficacious cannabis genetics and products to
supply Canada House’s growing patient base and
known demand. AbbaMedix.com
With Legalization fast approaching, through its subsidiaries, we will see an increased shareholder value. With Marijuana For Trauma Inc having 11 clinics and expanding, once legalization is official we might see some of those clinics becoming hybrid dispensaries which will increase revenue. On the international stage, Knalysis technologies, in recent months have been busy attending conferences such as CannaTech in Tel Aviv, Israel back in March, and a few conferences in North America, in hopes of increasing critical partnerships and continue to drive sales in key markets. Abba Medix Corp is CHV’s 100% owned subsidiary, which has a 22,000 sq foot facility in Pickering, Ontario, which can be expanded by another 27,500 sq feet for a total of 49,500 sq feet. Abba Medix Corp had received their cultivation license back in September 2017, and have made significant improvements to make sure they are on track to receive their license to sell in a timely manner.
Partners! Partners! Partners!
Canada House Wellness and Nutritional High (CSE:EAT) (OTCQB:SPLIF) (FRANKFURT:2NU) have a joint venture to manufacture cannabis oil extracts and cannabis-infused products in Canada. The joint venture will initially focus on building out an approximate 2,000 square foot area at Abba’s Pickering cannabis grow facility, to house a cannabis oil extraction operation focused on producing the oils and extracts currently permitted under ACMPR. As the Health Canada regulations continue to evolve, the Joint Venture will introduce additional products, all produced in accordance with Good Pharmacoepidemiology Practice guidelines so it can sell internationally.
Canada House Wellness entered into an exclusive licensing agreement with Medicine Man Technologies Inc. (OTCQB:MDCL) (“Medicine Man”), one of the United States’ leading cannabis branding and consulting companies, for deployment of its intellectual property and product lines (Three a Light ®, Success Nutrients ®, General Intellectual Property) into the Canadian marketplace.
To support their seed sales license Abba has secured an exclusive Canadian distribution agreement with a well-established UK
seed producer and now has access to more than 800 cannabis strains. More than 200 of these strains are immediately available
for sale by Abba Medix.
Compare Licensed Producers:
List of Canadian Marijuana Companies with Revenue over $500k
As per their most recent MD&A on www.sedar.com CHV finished quarter ending January 1st 2018, with a revenue of $789,868. This puts them 29th overall if we rank the marijuana companies by revenue out of close to 160 companies. If we rank these companies by fully diluted market/ revenue ratio CHV is 8th least overvalued company, which with talks of investors saying that some of the companies are overvalued, in CHV’s case they might not fall in that category.
Chv hasn’t been the busiest company in terms of news, but in recent weeks have made partnerships that will increase revenue and share holder value. With a licence to sell hopefully on it’s way, we’ll look forward to seeing what paths CHV take to complete becoming a vertically integrated company. Unfortunately, CHV is working on their investor’s presentation, look for a PART 2 to this article once the presentation is on their website.
Disclaimer: this article is for informational purposes only, we are not brokers or financial advisors, this is not for “buy” or “sell” purposes. We do have shares of CHV and do not plan to sell them within the next couple of day from this article. All data is taken from https://canadahouse.ca/, www.sedar.com, and google finance, quotes may be 15-20 minutes delayed.